160 Participants Needed

Shared Medical Appointments for Type 2 Diabetes

Recruiting at 1 trial location
FA
LC
Overseen ByLily Chao, MD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: Children's Hospital Los Angeles
Must be taking: Type 2 diabetes medications

Trial Summary

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, since it involves youth already prescribed medication for type 2 diabetes, it seems likely that you can continue your current treatment.

What data supports the effectiveness of the treatment Shared Medical Appointments for Type 2 Diabetes?

Research suggests that Shared Medical Appointments (SMAs) can improve blood sugar control and diabetes knowledge in patients with Type 2 Diabetes. These group appointments allow doctors to provide care to multiple patients at once, which can help manage diabetes more effectively.12345

Are shared medical appointments safe for people with diabetes?

The research on shared medical appointments for diabetes does not report any specific safety concerns, suggesting they are generally safe for use in humans.12467

How does the treatment of shared medical appointments differ from other treatments for type 2 diabetes?

Shared medical appointments for type 2 diabetes involve group sessions where multiple patients receive care and education from a physician at the same time. This approach is unique because it maximizes resources by allowing the physician to deliver consistent care to several patients simultaneously, potentially improving diabetes management and patient education compared to traditional one-on-one appointments.13457

What is the purpose of this trial?

The goal of this clinical trial is to learn if shared medical appointment is an acceptable way to deliver care to youth with type 2 diabetes.The main question\[s\] it aims to answer are:* Is shared medical appointments an acceptable care delivery model for this population?* Does shared medical appointment improve psychosocial outcomes for this population?Participants will attend quarterly clinic appointments and group activities and take surveys. Researchers will compare this intervention to standard of care.

Research Team

LC

Lily Chao, MD

Principal Investigator

Children's Hospital Los Angeles

Eligibility Criteria

This trial is for English-speaking youths aged 12-18 with type 2 diabetes who are on medication, and their caregivers if they speak English or Spanish. Participants must receive care at CHLA or UCSF and be willing to attend clinic visits, group sessions, and complete surveys.

Inclusion Criteria

Receives care for type 2 diabetes at either CHLA or UCSF
I am a young person who speaks English.
I am willing to go to clinic visits, join group sessions if needed, and fill out surveys.
See 3 more

Exclusion Criteria

Inability or unwillingness of individual to give written informed consent
Pregnancy
I am unable or unwilling to give consent for the trial.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants attend quarterly clinic appointments and group activities, and take surveys as part of the shared medical appointment model

1 year
4 quarterly visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Shared Medical Appointments
Trial Overview The TCT2 study is testing whether shared medical appointments are a good way to treat young people with type 2 diabetes. It compares the effectiveness of these group appointments against the usual one-on-one care by looking at how well patients accept this model and its impact on their mental health.
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: Shared Medical AppointmentActive Control1 Intervention
Participants will attend 4 quarterly appointments. In addition to time with their clinician, they will also have group activities that address relevant topics.
Group II: Standard CarePlacebo Group1 Intervention
Multidisciplinary team based care every 3 months.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's Hospital Los Angeles

Lead Sponsor

Trials
257
Recruited
5,075,000+

University of California, San Francisco

Collaborator

Trials
2,636
Recruited
19,080,000+

American Diabetes Association

Collaborator

Trials
148
Recruited
102,000+

Findings from Research

Shared medical appointments (SMAs) significantly improved key health indicators for diabetes patients, including a reduction in hemoglobin A1c levels by an average of 0.55 percentage points and systolic blood pressure by 5.2 mmHg, based on a review of 17 studies.
Despite these improvements in biophysical outcomes, the effectiveness of SMAs on LDL cholesterol levels was not significant, and there was not enough data to assess their impact on patient experience or healthcare costs.
Shared medical appointments for patients with diabetes mellitus: a systematic review.Edelman, D., Gierisch, JM., McDuffie, JR., et al.[2022]
Diabetes shared medical appointments (SMAs) significantly improved A1c levels in participants compared to usual care, with reductions of up to 0.53% for those attending at least half of the SMAs, based on a study involving 1537 adults with type 2 diabetes.
While SMAs showed immediate benefits in glycemic control, these improvements were not sustained at the 12-month follow-up, indicating a need for further research on long-term strategies to maintain these gains.
Evaluating the Effectiveness of Diabetes Shared Medical Appointments (SMAs) as Implemented in Five Veterans Affairs Health Systems: a Multi-site Cluster Randomized Pragmatic Trial.Heisler, M., Burgess, J., Cass, J., et al.[2022]
A systematic review of nine randomized trials involving various chronic illnesses (excluding diabetes and mental health) found that shared medical appointments do not negatively impact patient quality of life, knowledge, or satisfaction compared to usual care.
Patients attending shared medical appointments experienced fewer hospital admissions, suggesting potential benefits for healthcare systems, although more rigorous studies with larger sample sizes are needed to confirm these findings.
Shared medical appointments for patients with a nondiabetic physical chronic illness: A systematic review.Kelly, F., Liska, C., Morash, R., et al.[2019]

References

Shared medical appointments for patients with diabetes mellitus: a systematic review. [2022]
Evaluating the Effectiveness of Diabetes Shared Medical Appointments (SMAs) as Implemented in Five Veterans Affairs Health Systems: a Multi-site Cluster Randomized Pragmatic Trial. [2022]
Shared medical appointments for patients with a nondiabetic physical chronic illness: A systematic review. [2019]
Shared Medical Appointments and Their Effects on Achieving Diabetes Mellitus Goals in a Veteran Population. [2020]
Shared Medical Appointments May Be Effective for Improving Clinical and Behavioral Outcomes in Type 2 Diabetes: A Narrative Review. [2019]
Implementation and Evaluation of Shared Medical Appointments in Veterans With Diabetes: A Quality Improvement Study. [2019]
The use of shared medical appointments in the care of the elderly. [2013]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security